Analysis·2026-06-01·3 min read

Blood Inflammation Markers Don't Predict Who Will Develop Chronic Musculoskeletal Pain

A major UK study following 7,564 people found that blood levels of C-reactive protein and vitamin D don't reliably predict who will develop chronic pain in the neck, back, hips, or knees.

By Editorial Team
Link Copied!

Key Takeaways

  • Blood inflammation markers like CRP don't predict chronic musculoskeletal pain when lifestyle and psychological factors are considered
  • Vitamin D levels showed no connection to future chronic pain development in any body region
  • The study challenges common assumptions about using blood tests to identify pain risk
  • Biopsychosocial factors appear more important than blood markers for chronic pain development

For years, researchers have suspected that inflammation in the blood might predict who will develop chronic musculoskeletal pain. The theory seemed logical: higher levels of C-reactive protein (CRP), a marker of inflammation, and lower vitamin D levels appeared connected to pain conditions in smaller studies. But a comprehensive analysis of nearly 8,000 people followed for up to seven years reveals a more complex picture.

What the Largest Study of Its Kind Found

Researchers from the UK Biobank study tracked 7,564 people who were completely pain-free at the beginning of the study between 2006 and 2010. They measured blood levels of CRP and vitamin D, then followed up 2-7 years later to see who had developed chronic musculoskeletal pain in their neck, shoulders, back, hips, or knees.

The results revealed a striking pattern: while people who developed chronic pain did have slightly higher initial CRP levels (1.21 mg/L compared to 1.03 mg/L in those who stayed pain-free), this difference disappeared once researchers accounted for lifestyle and psychological factors like stress, depression, physical activity, and socioeconomic status.

Key Finding

After accounting for biopsychosocial and lifestyle factors, blood inflammation markers showed no reliable connection to chronic musculoskeletal pain development

This challenges the common medical assumption that blood tests can predict pain risk

Vitamin D levels showed no association with chronic pain development in any of the analyses, contradicting previous smaller studies that suggested low vitamin D might increase pain risk.

Debunking the 'Inflammation Causes Pain' Misconception

Many people assume that systemic inflammation directly leads to chronic musculoskeletal pain. This belief has led to widespread testing of CRP and vitamin D in pain patients, with the hope that treating these markers might prevent or reduce chronic pain.

However, this study suggests the relationship is far more nuanced. While inflammation may play a role in pain conditions, the systemic markers measurable in blood don't appear to predict who will develop chronic musculoskeletal pain when other important factors are considered.

The misconception likely arose because earlier studies were smaller and didn't account for the complex web of factors that influence pain development. When researchers look only at inflammation markers without considering stress levels, physical fitness, mental health, and social circumstances, they might see connections that don't hold up under more rigorous analysis.

How This Study Differs from Previous Research

Previous StudiesThis UK Biobank Study
Small sample sizes (typically hundreds)7,564 participants tracked
Limited follow-up periods2-7 year comprehensive follow-up
Basic analysis of inflammation markers onlyAdjusted for biopsychosocial and lifestyle factors
Found associations between CRP and painNo association after full adjustment
Some suggested vitamin D connectionsNo vitamin D association found

What Really Matters for Chronic Musculoskeletal Pain Prevention

The study's most important finding may be what it reveals about the factors that do matter for chronic pain development. When researchers controlled for biopsychosocial and lifestyle factors—including mental health status, physical activity levels, stress, and social circumstances—the apparent connection between inflammation markers and pain vanished.

This suggests that psychological wellbeing, lifestyle choices, and social support may be far more influential in determining who develops chronic musculoskeletal pain than simple blood measurements. The biopsychosocial model of pain—which considers biological, psychological, and social factors together—appears to be more predictive than focusing on inflammation alone.

Key Numbers from the Study

20.2%
Developed chronic musculoskeletal pain during follow-up
7,564
Pain-free people tracked over years
1.21 mg/L
Average CRP in those who developed pain
No association
Between vitamin D and future pain risk

What This Means for Your Health Decisions

If you're concerned about developing chronic musculoskeletal pain, this research suggests that focusing solely on blood inflammation markers or vitamin D levels may not be the most effective approach. While these markers can indicate other health issues worth addressing, they don't appear to reliably predict chronic pain risk.

Instead, you might benefit more from addressing modifiable lifestyle and psychological factors. This could include managing stress effectively, maintaining regular physical activity appropriate for your fitness level, seeking support for mental health concerns, and building strong social connections.

Questions for Your Doctor

If you're concerned about chronic pain risk or have been tested for inflammation markers, consider asking:

  • Should I focus on CRP or vitamin D levels for pain prevention?
  • What lifestyle factors might most influence my pain risk?
  • How can I address stress and mental health to support pain prevention?
  • What early signs of developing chronic pain should I watch for?

What This Study Doesn't Tell Us

While this study provides valuable insights, it focused on systemic inflammation markers in the blood. It doesn't rule out the role of localized inflammation at injury sites or other inflammatory processes that might not show up in standard blood tests. The research also doesn't examine whether treating inflammation might help people who already have chronic musculoskeletal pain. Additionally, the study population was primarily from the UK, so results may not apply equally to all populations or ethnic groups.

Future research will likely explore more sophisticated inflammatory markers and investigate how they interact with psychological and social factors in chronic pain development. Scientists may also examine whether localized inflammation at specific body sites provides better predictive information than systemic blood markers.

Sources & References

  1. Collyer MR, Sterling M, Armfield NR, Xie Y, Cabot PJ, Elphinston RA, Klyne DM, Farrell SF. "Systemic C-reactive protein and vitamin D are not associated with development of chronic musculoskeletal pain over a 2-7 year follow-up period." - The journal of pain (2026)

Medical Disclaimer: The information provided on ChronicRelief.org is intended for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.